Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites
This protocol evaluates whether empagliflozin, added to standard therapy, increases sodium excretion and reduces fluid overload in refractory ascites.
Authors
- Yuan Gao (ORCID: https://orcid.org/0000-0002-0670-9104)
- Ying Han (ORCID: https://orcid.org/0000-0002-1791-6870)
- Yunyi Gao (ORCID: https://orcid.org/0000-0003-3780-3942)
- Zhong Hu (ORCID: https://orcid.org/0000-0002-1521-8294)
- Liang Xu (ORCID: https://orcid.org/0000-0002-9039-6621)
- Qingcui Bu (ORCID: https://orcid.org/0000-0001-5238-3988)
- Menghua Wu (ORCID: https://orcid.org/0000-0003-0459-3723)
- Hoydoo You (ORCID: https://orcid.org/0000-0003-2996-9483)
- Qi Wang (ORCID: https://orcid.org/0000-0002-5324-8988)
- Dong Ji
- Lu Zhou (ORCID: https://orcid.org/0000-0002-0424-7348)
- Xinyu Zhang (ORCID: https://orcid.org/0000-0001-8154-9334)
- Wei Liu (ORCID: https://orcid.org/0000-0002-0236-7071)
- Yu Wang (ORCID: https://orcid.org/0000-0003-2265-3742)
- Wei Hou (ORCID: https://orcid.org/0000-0002-7208-7243)
- Ruifeng Shi (ORCID: https://orcid.org/0000-0002-6493-9776)
- Yugang Dong (ORCID: https://orcid.org/0009-0001-0668-8788)
- Qingkun Song
Institutions
- Capital Medical University (CN)
- Chinese Academy of Sciences (CN)
- Tianjin People's Hospital (CN)
- Academy of Mathematics and Systems Science (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.4254/wjh.v17.i10.110247
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00